Preliminary Program: Wednesday, May 23
8 a.m.-Noon
CME Courses 76-82
9 a.m.-4 p.m.
CME Courses 83-87
9 a.m.-10:30 a.m.
Component Workshops
CW37. Career Advancement in Administrative Psychiatry for Early Career PsychiatristsAPA Assembly Committee of Early Career Psychiatrists; Chair: Dimitri D. Markov, M.D.
CW38. The Sacred Herb and Addiction Science: A Study of Nicotine Dependence and Axis I Comorbidities Among American IndiansAPA Committee of American Indian, Alaska Native, and Native Hawaiian Psychiatrists; Chair: Daniel L. Dickerson, D.O.
CW39. Transcultural Arab Psychiatry With a Focus on Women's Mental HealthAPA Arab American Psychiatric Association; Chair: Ossama T. Osman, M.D.
CW40. Suicide Icon: The Golden Gate BridgeAPA Northern California Psychiatric Society; Chair: Mel Blaustein, M.D.
CW41. Lessons Learned From Business Practices: How Can Psychiatrists Increase Their Practice Opportunities by Implementing Successful Business StrategiesAPA Committee on APA/Business Relations; Chair: Gabriela Cora-Locatelli, M.D.
CW42. Social Dimensions of Disasters and Community RecoveryAPA Committee on Psychiatric Dimensions of Disasters; Chair: Jacqueline Henschke, M.D.
CW43. The Isms: How Racism, Sexism, Classism, and Heterosexism Affect Mental Health CareAPA/SAMHSA Minority Fellows; Chair: Karen R. Liaw, M.D.
CW44. Managed Care, Psychiatrists, and Employers: Collaborating Effectively to Ensure Patient CareAPA Committee on Managed Care; Chair: Paul Henry Wick, M.D.
CW45. Racism, Racial Discrimination, and Xenophobia: How Psychiatry Can Reduce Their Adverse Effects on Mental HealthAPA Council on Minority Mental Health and Health Disparities; Chair: Francis G. Lu, M.D.
Issue Workshops
IW51. Biopsychosocial and Spiritual Aspects of Treating Our Physician ColleaguesChair: Syed S. A. Naqvi, M.D.
IW52. Responding to the Impact of Suicide on CliniciansChair: Eric M. Plakun, M.D.
IW53. Developing Research Training Opportunities Within a Psychiatric Residency Training Program: Goals, Motivations, Barriers, and SolutionsChair: Robert J. Love, D.O.
IW54. The ADHD/Pediatric Bipolar Interface: Sailing Through Troubled Waters?Chair: Vishal Madaan, M.D.
IW55. Oral Boards Boot Camp: 2007Chair: Elyse D. Weiner, M.D.
IW56. Neuroimaging Research: Implications for the Treatment of Substance AbuseNational Institute on Drug Abuse; Chair: Steven J. Grant, Ph.D.
IW57. Project Match: A Resident Curriculum of Mentorship, Advocacy, Teaching, Career Issues, and HealthChair: Heather L. Flett, M.D.
IW58. The Resident Experiences a Patient Suicide: Strategies That Can HelpChair: Joan M. Anzia, M.D.
IW59. Telepsychiatry in Action: Implementing and Sustaining a Successful Telepsychiatry ProgramChair: Amir A. Khan, M.D.
IW60. Research Training for All Psychiatric Residents: A Problematic EndeavorChair: Milton Kramer, M.D.
IW61. Detecting Bipolar DisorderChair: Gary E. Miller, M.D.
IW62. Can We Do Better at Preventing the Chronic Course of Mood Disorders?Chair: Alina Marin, M.D.
IW63. Safety Training for Medical Students During Their Psychiatry ClerkshipChair: Erica Z. Shoemaker, M.D.
IW64. The Role ofDSM-IVRating Scales in PsychiatryChair: Joyce Sprafkin, Ph.D.
Lectures
L20.Lawrence Hartmann, M.D., APA's John Fryer Award Lecture
9 a.m.-Noon
Media Workshops
MP5. Rock Bottom: Understanding the Methamphetamine Experience and the Struggle for SobrietyChair: Steven J. Lee, M.D.
MP6. “We Are Dad”: HIV-Positive Children and Lesbian, Gay, Bisexual, or Transgender ParentingChair: R. Kaan Ozbayrak, M.D.
MP7. Psychiatric Residents' Perspective of Couples and Family Therapy TrainingChair: Ian E. Alger, M.D.
9 a.m.-12:30 p.m.
Advances In
Advances in Geriatric PsychiatryDan Blazer, M.D.
11 a.m.-12:30 p.m.
Component Workshops
CW46. Leadership Challenges: Breaking Barriers to SuccessAPA Committeeon International Medical Graduates; Chair: Antony Fernandez, M.D.
CW47. Public Policy, HIV, and Mental Health: Politics, Ideology, or ScienceAPA New York County District Branch's AIDS Committee; Chair: Mary Ann Cohen, M.D.
CW48.CPTCoding and Documentation UpdateAPA Committee on RBRVS, Codes, and Reimbursements; Chair: Ronald M. Burd, M.D.
CW49. Ethics and Etiquette: Keeping Out of TroubleAPA Ethics Committee; Chair: Wade C. Myers, M.D.
CW50. Managing Opiate Detoxification With Buprenorphine/NaloxoneAPA Council on Addiction Psychiatry; Chair: John A. Renner Jr., M.D.
CW51. New APA Practice Guidelines on Dementia, Panic Disorder, and OCDAPA Steering Committee on Practice Guidelines; Chair: John S. McIntyre, M.D.
CW52. Mission Possible: Reclaiming America's State Hospital BedsAPA Council on Social Issues and Public Psychiatry; Chair: Tracee Burroughs, M.D.
CW53. Early Cognitive Development and Psychiatric Presentation: Implications for Etiologic Understanding and InterventionAPA Corresponding Committee on Infancy and Early Childhood; Chair: Jean M. Thomas, M.D.
CW54. Mentoring of Women in Academic PsychiatryAPA Central California Psychiatric Society; Chair: Linda L.M. Worley, M.D.
Issue Workshops
IW65. Complexities of Post-Termination RelationshipsChair: Malkah T. Notman, M.D.
IW66. Ethnicity, Culture, and Psychopharmacology: Recent AdvancesChair: Pedro Ruiz, M.D.
IW67. Cognitive-Behavior Therapy for Psychosis in Practice: Basic Techniques for PsychiatristsChair: Shanaya Rathod, M.D.
IW68. Promising Medications for the Treatment of Cocaine AddictionNational Institute on Drug Abuse; Chair: Ahmed Elkashef, M.D.
IW69. Psychiatrists Who Have Been in Treatment: An Interactive DiscussionChairs: Michael F. Myers, M.D., Leah J. Dickstein, M.D.
IW70. Electrifying Discourses: Presentation and Communication Skills for Psychiatrists and TraineesChair: Shyam K. Bhat, M.D.
IW71. Air Force Suicide Prevention Program: A Community and Organizational Approach to PreventionChair: Steven E. Pflanz, M.D.
IW72. Day-to-Day Variability in Bipolar DisorderChair: Jan L. Scott, M.D.
IW73. From the Mississippi to the Ganges: Understanding the Cross-Cultural Context of Treatment From the Perspective of the South-Asian Psychiatrist in AmericaIndo-American Psychiatric Association; Chair: Sudeepta Varma, M.D.
IW74. Religious and Spiritual Assessment in Clinical PracticeChair: Francis G. Lu, M.D.
IW75. From Evidence to Clinical Methods in Integrative Mental Health CareChair: James Lake, M.D.
IW76. Gay Men and Crystal Methamphetamine: A ReviewChair: Eugene Lee, M.D.
Lectures
L21.Nancy C. Andreasen, M.D., APA's Judd Marmor Award Lecture
L22.William T. Carpenter, M.D., Distinguished Psychiatrist Lecture Series
Scientific and Clinical Reports Session 19. Psychopharmacology and Schizophrenia
55.Number Needed to Treat and Number Needed to Harm: Making Sense of CATIE Leslie L. Citrome, M.D.
56. Switching From Long-Acting Typical Antipsycotic Drugs to the Second-Generation Antipsychotics Olanzapine and Risperidone in the Treatment of Chronic Schizophrenia Patients Marnina Swartz-Vanetik, M.D.
57. zolpidem in Treatment-Resistant Catatonia: Two Case Reports and Literature Review Cristinel M. Coconcea, M.D.
Session 20. Managing Violence
58. Variables Affecting Violence That Required Physical Restraint Among Psychiatric Inpatients During the First Week of Hospitalization Pinkhas Sirota, M.D.
59. Decreasing the Use of Restraint and Seclusion Among Psychiatric Inpatients David J. Hellerstein, M.D.
60. CES Reduces Aggression in Violent Neuropsychiatric Patients Allen Childs, M.D.
Session 21. Continuation and Discontinuation of SSRIs
61. Comparison of the Prophylactic Efficacy of Antidepressants—Factors Associated With Better Outcome Sabrina J. Khan, M.D.
62. How Often Do SSRIs Lose Their Effect During Continuation Treatment? Evidence Suggesting the Rate Is True Tachyphylaxis During Continuation Treatment Is Low Mark Zimmerman, M.D.
63. Discontinuation of SSRIs After Five years' Stability Tara M. Pundiak, M.D.
Session 22. Sex, Attraction, and Intimacy
64. An Eight-Week Randomized, Double-Blind, Placebo-Controlled Trial of PDE5I Sildenafil Treatment of SRI-Antidepressant-Associated Sexual Dysfunction in Women With Major Depression Disorder in Remission: Identifying a Hormone Endophenotype Associated With Treatment H. George Nurnberg, M.D.
65. Breakthrough Intimacy—Treating Personality Yukio Ishizuka, M.D.
66. A Link Between Oxytocin and Anxiety of Romantic Attachment Donatella Marazziti, M.D.
Session 23. Psychopharmacology and Bipolar Disorder
67. Effect of Comorbid Anxiety on Antidepressant Use in a Community Sample of Bipolar Subjects Ayal Schaffer, M.D.
68. Difficult-to-Treat Patients: The Role of Quetiapine in the Management of Acute Bipolar Depression (With a Focus on Bipolar II Patients) Michael E. Thase, M.D.
69. Indirect Comparison of the Safety and Tolerability of Antipsychotics in Patients With Bipolar Disorder and Schizophrenia Keming Gao, M.D.
Session 24. Treatment Issues in College and Medical Students
70. Subjective Sleep Quality and Suicidal Ideation Among College Students Shamsah B. Sonawalla, M.D.
71. Prevalence and Attitudes Concerning ADHD Diagnosis and Use of Stimulant Medications in Medical Students Jeffrey Tuttle, M.D.
72. Prevalence and Symptom Patterns of Depression Among College Students: Findings From a Cross-Cultural Study Across Boston and Bombay Rajesh M. Parikh, M.D.
Session 25. Functioning and Disease Burdens in Mood Disorders
73. Disease Burden of Bipolar and Schizoaffective Disorder in an Australian Cohort Jayashri Kulkarni, M.B.B.S.
74. Days Missed From Work in Patients With Major Depressive Disorder With or Without a Personality Disorder Daniela A. Boerescu, M.D.
75. The Relationship Between Global Functioning, Depression, and Painful Somatic Symptoms in Patients With Major Depressive Disorder Thomas N. Wise, M.D.
Session 26. Stigma and Discrimination
76. How Dangerous Is Stigma? Perceived Stigma and HIV Risk Among Women With Severe Mental Illness Pamela Y. Collins
77. Comparison of Public's Stigma Attitude Between Mental Illness and Physical Handicap Chih-Wei Yang, M.D.
78. Obsessions About Homosexuality and the y-BOCS—Lessons From an Antidiscrimination Case in Sweden Christian Rück, M.D.
Session 27. Suicide and Self-Destruction
79. The 10-year Course of Physically Self-Destructive Acts of Patients With Borderline Personality Disorder Mary C. Zanarini, Ed.D.
80. Indicators of Treatment-Refractory Illness and Risk of Suicide John W. Goethe, M.D.
81. Personality Traits as Prospective Predictors of Suicide Attempts: Negative Affectivity/Temperament and Disinhibition in a Personality Disorder Sample Shirley Yen, Ph.D.
1 p.m.-5 p.m.
CME Courses 88-91
2 p.m.-3:30 p.m.
Lectures
L23. Psychosis on the Streets: An Ethnography of Chicago's NetherworldTanya Luhrmann, Ph.D., Frontiers of Science Lecture Series
L24.Leah J. Dickstein, M.D., Distinguished Psychiatrist Lecture Series
2 p.m.-5 p.m.
Presidential Symposia
5. Health Inequalities for Persons With Mental Health Problems and Developmental DisabilitiesRoyal College of Psychiatrists; Chair: Sheila Hollins, M.B.
6. Focusing on European PsychiatryAPA Council on Global Psychiatry; Chair: Pedro Ruiz, M.D.
7. Globalization and Mental Health: Role of Spanish-Speaking PsychiatryChair: Renato D. Alarçon, M.D.
Symposia
S52. Behavioral and Substance Addictions in Minority Populations
Implications of Black/African-American Race, Ethnicity, and Culture for Addiction Marc N. Potenza, M.D. | |||||
To Be Announced Joseph J. Westermeyer, M.D. | |||||
Asian Americans, Addictions, and Barriers to Treatment Timothy W. Fong, M.D. | |||||
Addictions Within the Gay and Lesbian Community Jon E. Grant, M.D. | |||||
Clinical Challenges to Addiction Treatment Within the Latino Community Carlos Blanco-Jerez, Ph.D. | |||||
S53. Treatment of Depression in the Medically Ill: An Update From Recent Clinical Trials
The CREATE Trial: Background and Design of a 2 by 2 Factorial Randomized Trial of Citalopram and IPT for Major Depression in Patients With Coronary Artery Disease Nancy Frasure-Smith, Ph.D. | |||||
The CREATE Trial: Results of a 2 by 2 Factorial Randomized Trial of Citalopram and IPT for Major Depression in Patients With Coronary Artery Disease François Lespérance, M.D. | |||||
Randomized Controlled Trial of Treatments for Depression After Coronary Bypass Surgery Kenneth E. Freedland, Ph.D. | |||||
Cost-Effectiveness or Improving Depression Outcomes in Patients With Diabetes and Depression Wayne J. Katon, M.D. | |||||
Efficacy of Sertraline for Prevention of Depression Recurrence in Older vs. Younger Adults With Diabetes Patrick J. Lustman, Ph.D. | |||||
S54. Drug Abuse Treatment Within the Criminal Justice System: Addressing Our Nation's Public Health Needs
Findings From a National Survey of Correctional Agencies on Substance Abuse Treatment and Health Services: Who Can Get Served? Faye S. Taxman, Ph.D. | |||||
The Long-Term Effectiveness of Corrections-Based Treatment for Drug-Involved Offenders James A. Inciardi, Ph.D. | |||||
Mental Health and Co-Occurring Treatment Needs of Individuals in the Criminal Justice System Roger H. Peters, Ph.D. | |||||
Meeting the Medical Needs of Offenders Peter D. Friedmann, M.D. | |||||
Pharmacotherapy in Correctional Settings for Addictive and Other Mental Disorders Robert P. Schwartz, M.D. | |||||
S55. Improving Cross-Cultural Competency in Psychiatric Practice
South-Asian Psychiatrist Providing Culturally Sensitive Treatment Rama Rao Gogineni, M.D. | |||||
Cultural Competency in Psychiatry and African Americans Altha J. Stewart, M.D. | |||||
Filipino Families and Mental Health: Understanding Their Perspectives Consuelo Cagande, M.D. | |||||
Latinos in the United States: Cross-Cultural Issues Maria Velazquez, M.D. | |||||
S56. Eating Behavior in Schizophrenia: Biological and Clinical Implications
Obesity and Metabolic Disorders in Schizophrenia Naveed Iqbal, M.D. | |||||
Eating Disorders in Schizophrenia: Conceptual and Clinical Issues Michael Y. Hwang, M.D. | |||||
Phenomenological and Clinical Profiles of Eating Behavior in Schizophrenia Sun Young Yum, M.D. | |||||
Effect of Atypical Antipsychotics on Obesity and Metabolism in Schizophrenia Palmiero Monteleone, M.D. | |||||
S57. Simple Technologies to Improve Psychotherapy
Web-Based Learning in Psychotherapy: A Demonstration Priyanthy Weerasekera, M.D. | |||||
Seeing Is Believing: Webcams in Psychotherapy Supervision John Manring, M.D. | |||||
Evidence for Measuring, Monitoring, and Feeding Back Progress Information to Providers: Technology in the Service of Improving Patient Outcome Michael J. Lambert, Ph.D. | |||||
Using Technology in Cognitive Therapy Judith S. Beck, Ph.D. | |||||
S58. Psychiatric Training Across the Continents: International Young Psychiatrist Perspectives
From the Old to the New: Changes to Postgraduate Psychiatric Training in the U.K. Amit Malik, M.B.B.S. | |||||
Psychiatric Training in Kenya: An African Perspective Violet A. Okech, M.B.Ch.B., M.Med. | |||||
The Specialist Training in Psychiatry in Bolivia and Latin America Guillermo C. Rivera Arroyo Sr., Ph.D. | |||||
Psychiatric Training Program in Japan Atsuo Nakagawa, M.D. | |||||
The Interface Between East and West: Psychiatric Training in Turkey Ozgur Ozturk, M.D. | |||||
Review of Psychiatric Training in the United States Abigail L. Donovan, M.D. | |||||
S59. American Psychiatry Viewed From the Outside: A Global Perspective on theDSMsand Psychopharmacology
To Be Announced Eduardo A. Correa | |||||
U.S. Influence on the Evolution of European Psychiatry Athanasios Koukopoulos, M.D. | |||||
The View From the Middle East Kemal Sayar, M.D. | |||||
The Rise and Fall of American Psychiatry Nassir Ghaemi, M.D. | |||||
S60. The End, Middle, and Beginning of the Affair: Infidelity in Film and Television
Do Married People Have Affairs Because They Can't Help It? Lessons From the History of Marriage Anton C. Trinidad, M.D. | |||||
Why We Think People Cheat Robert J. Boland, M.D. | |||||
S61. Connections to Medical Information
To Be Announced Britton A. Arey, M.D. | |||||
S62. Prescribing Patterns, Predictors, and Costs for Antidepressant Medications
Changes in Prescribing When Antidepressants Become Generic Ronald J. Diamond, M.D. | |||||
To Be Announced Marion Ann Becker, Ph.D. | |||||
Retrospective Analysis of Public Payer Health Care Costs Associated With Specific Types of Antidepressant Treatment for MDD Paul Stiles, Ph.D. | |||||
Recent Patterns and Predictors of Antidepressant Medication Regimens Used to Treat Major Depressive Disorder M. Scott Young, Ph.D. | |||||
S63. Neurobiology of the Unconscious: Implications for Psychotherapeutic Understanding and Technique
Historical Overview of the Concept of the Unconscious Barton J. Blinder, M.D. | |||||
Mapping the Unconscious in the Brain George I. Viamontes, M.D. | |||||
The Mirror Neuron System Marco Iacoboni, M.D. | |||||
Unconscious Enactments in Psychotherapy Glen O. Gabbard, M.D. | |||||
Metacommunication, Psychotherapy, and the Brain Bernard D. Beitman, M.D. | |||||
S64. Update on the Biology of Personality Disorders
New Developments in Neurocircuits and Neurotransmitters in the Personality Disorders Larry J. Siever, M.D. | |||||
Biology and Treatment of Impulsive Aggression in Personality Disorder Emil F. Coccaro, M.D. | |||||
NMDA Neurotransmission and the Neurobiology of BPD Bernadette M. Grosjean, M.D. | |||||
Pain Processing in Borderline Personality Disorder Christian Schmahl, M.D. | |||||
5HT2a Receptor Binding in Borderline Personality Disorder Paul H. Soloff, M.D. | |||||
A Neurodevelopmental Model of Borderline Personality Disorder Kenneth R. Silk, M.D. | |||||
S65. A Picture of the Development of the Adolescent Brain: A Structural and Functional Assessment
Mapping Adolescent Brain Maturation With Structural Magnetic Resonance Imaging Elizabeth R. Sowell, Ph.D. | |||||
To Be Announced Michael J. Rivkin, M.D. | |||||
Magnetic Resonance Spectroscopy Studies of Human Brain Development Perry F. Renshaw, M.D. | |||||
Risk Taking and the Adolescent Brain: Who Is at Risk? B.J. Casey, Ph.D. | |||||
S66. An Update on Cross-Cultural, Ethnic, and Ethnopsychopharmacological Aspects of Mood Disorders
Ethnopsychopharmacology David C. Henderson, M.D. | |||||
Psychiatric Management of Hispanic Patients: Cross-Cultural Issues and Ethnopsychopharmacology David Mischoulon, M.D. | |||||
Culturally Sensitive Collaborative Treatment of Depressed Chinese Americans in Primary Care Albert S. Yeung, M.D. | |||||
Cultural Considerations in the Diagnosis and Treatment of Mood Disorders in the Asian-Indian Population Rajesh M. Parikh, M.D. | |||||
A Cultural Perspective on the Diagnosis and Treatment of Mood Disorders in Women Shamsah B. Sonawalla, M.D. | |||||
S67. Ethics of Treating Subsyndromal Psychiatric Disorders
Should We Treat Subsyndromal Psychiatric Disorders? Ahmed M. Okasha, M.D. | |||||
Subthreshold Mood States Are Not Subclinical Hagop S. Akiskal, M.D. | |||||
Treating Subsyndromal Schizophrenia: Why the Uproar? Thomas H. McGlashan, M.D. | |||||
Defining the “Threshold” for the Diagnosis of Mental Disorder: Some Current Approaches Mario Maj, M.D. | |||||
S68. Innovations in the Treatment of Adolescent Substance Use Disorders
Fluoxetine in Adolescents With Comorbid Major Depressive Disorder and an Alcohol-Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial Jack R. Cornelius, M.D. | |||||
Evidence for Adolescent Participation in Alcoholics Anonymous and Narcotics Anonymous: Further Steps Needed John F. Kelly, Ph.D. | |||||
Does Smoking Cessation Intervention Influence Adolescent Alcohol and Other Drug Abuse Treatment Outcome? Mark G. Myers, Ph.D. | |||||
Aftercare for Adolescent Alcohol-Use Disorders Yifrah Kaminer, M.D. | |||||
S69. Sexuality in Long-Term-Care Facility Residents
Normal Aging and Sexuality in Later Life Helen H. Kyomen, M.D. | |||||
To Be Announced Robert K. Dolgoff, M.D. | |||||
Assessment and Management of Inappropriate Sexual Behavior in the Long-Term-Care Setting David D. Myran, M.Ed. | |||||
Sexuality and Rights of Residents in Long-Term-Care Facilities Ken Schwartz, M.D. | |||||
S70. The Sexually Violent Offender
Civil Commitment of Sex Offenders Howard V. Zonana, M.D. | |||||
The Civil Facility Experience With a Program for SVPs Samuel J. Langer | |||||
Risk Assessment and Treatment Issues Related to Paraphilic Sex Offenders Fabian M. Saleh, M.D. | |||||
The Role of Treatment Outcome in the SVP Courtroom Howard E. Barbaree, Ph.D. | |||||
Treatment of Sex Offenders in a Prison Setting Lawrence A. Siegel, M.D. | |||||
S71. Prenatal Nicotine Exposure: How Does It Relate to Developmental Vulnerabilities?
Beyond Diagnosis: Unpacking the Association of Prenatal Smoking and Exposure Across Developmental Periods Lauren Wakschlag, Ph.D. | |||||
Neuroimaging Evidence of Altered Medial Temporal Lobe Function in Adolescent Tobacco Smokers With Prenatal Exposure to Maternal Smoking Leslie K. Jacobsen, M.D. | |||||
Gestational Nicotine Alters Brain Nicotinic Cholinergic Receptor Expression in Dopaminergic Regions of Adolescents and Adults Burt Sharp, M.D. | |||||
Prenatal Nicotine Exposure Induces Sex-Dependent Changes in Dopamine Pathways in Adolescent Brain Frances Leslie, Ph.D. | |||||
S72. The IOM Informs, NAMI Storms, and AACP Transforms: How to Make the Grade in Response to the U.S. Mental Health System's Bad Report Card
Can Community Psychiatry Cross the Quality Chasm? The Institute of Medicine Report on Improving Care for Mental and Substance-Use Conditions Harold A. Pincus, M.D. | |||||
What Families and Consumers See and Want in America's Mental Health Service System Kenneth S. Duckworth, M.D. | |||||
Leadership and Collaboration: Transforming Community Psychiatry Wesley E. Sowers, M.D. | |||||
Getting the Word Out: How to Synthesize, Disseminate, Implement, and Support the IOM's Recommendations Neal H. Adams, M.D. | |||||
S73. HIV Update for Psychiatric Care
HIV Medical Update: What Every Psychiatrist Needs to Know Diane Pennessi | |||||
Evidence-Based Treatments in HIV Psychiatric Care Stephen Ferrando, M.D. | |||||
HIV as a Lifelong Illness Karl Goodkin, M.D. | |||||
S74. Dissociative Disorders: Meeting the Challenge ofDSM-V
Dissociative Disorders: History, Conceptual Issues, Diagnosis, and Research Richard J. Loewenstein, M.D. | |||||
Dissociative Identity Disorder (DID) and DID-Like Cases of Dissociative Disorder Not Otherwise Specified Paul F. Dell, Ph.D. | |||||
Depersonalization Disorder and Dissociative Amnesia Daphne Simeon, M.D. | |||||
Conversion Disorder, Dissociative Psychosis, and Childhood Dissociative Disorder Vedat Sar, M.D. | |||||
2 p.m.-5:30 p.m.
Advances In
Advances in C-L Psychiatry and Psychosomatic MedicineJames L. Levenson, M.D.
7 p.m.-10 p.m.
Industry-Supported Symposium
IS32. Fibromyalgia: New Insights Into the Pathophysiology and TreatmentSupported by Pfizer Inc.
The Pathophysiology of Pain in Fibromyalgia and Related Syndromes Daniel J. Clauw, M.D. | |||||
The Role of Disordered Sleep in Fibromyalgia Lesley M. Arnold, M.D. | |||||
New Developments in the Pharmacological Treatment of Fibromyalgia Leslie J. Crofford, M.D. | |||||
Exercise as a Treatment for Fibromyalgia Dina Dadabhoy, M.D.▪ | |||||
